In the United States alone, an estimated 15.3 million new cases of STDs are reported each year. Out of those figures chlamydia is close to four million cases; gonorrhea two million cases; and Syphilis the third most frequently reported communicable disease in the United States.
Coinfection of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC) is most common. In fact, up to half of patients diagnosed with either infection may be infected with both and, therefore, it is very important to test for both Chlamydia and Gonorrhea infection at the same time.
The brand leader in helping health care professionals with the early identification to the presence of STD infection in patients by providing the highest quality point-of-care (POC) Testing Products to doctors, hospitals & STD clinics for Chlamydia, Gonorrhea and Syphilis...
Rapid Test Benefits:
Registered Medical Device
On-the-spot testing in both men and women
The ability to stem the development of health complications at an early stage
Prevention of unnecessary anxiety waiting for test results
Easily performed test results in minutes interpreted by all personnel
Laboratory Accuracy Colloidal Gold Technology with Built-in test controls
High Sensitivity & Specificity to ensure proper diagnosis
Uses multiple specimen types; minimizes specimen incompatibility and rejection
Long Shelf Life, Room Temperature Storage of Test Card
No additional instrumentation required
First Diagnostic manufacturing the latest in Antigen & Antibody Detection Tests. These market-proven, flow-through membrane technology platforms are used to quickly and efficiently develop rapid tests for many health conditions.
The brand leader in